デフォルト表紙
市場調査レポート
商品コード
1089755

生物製剤受託製造の世界市場:製品別、プラットフォーム別、治療領域別、地域別、2027年までの予測 - COVID-19の累積影響

Biologics Contract Manufacturing Market Research Report by Product, Platform, Therapeutic Area, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 214 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
生物製剤受託製造の世界市場:製品別、プラットフォーム別、治療領域別、地域別、2027年までの予測 - COVID-19の累積影響
出版日: 2022年06月15日
発行: 360iResearch LLP
ページ情報: 英文 214 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の生物製剤受託製造の市場規模は、16.32%のCAGRで推移し、2027年までに419億2,000万米ドルに達すると予測されています。

当レポートでは、世界の生物製剤受託製造市場について調査し、市場の促進要因、抑制要因、市場機会、課題、製品別・プラットフォーム別・治療領域別・地域別の市場分析、競合情勢、企業プロファイルなどを提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーション・範囲
  • 調査対象期間
  • 通貨・価格
  • 言語
  • 制限事項
  • 前提条件
  • 利害関係者

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • COVID-19の累積的影響

第6章 製品別の生物製剤受託製造市場

  • バイオシミラー
  • インスリン
  • インターフェロン
  • モノクローナル抗体
  • 遺伝子組換えホルモン
  • ワクチン

第7章 プラットフォーム別の生物製剤受託製造市場

  • 哺乳類
  • 微生物

第8章 治療領域別の生物製剤受託製造市場

  • 自己免疫疾患
  • 心血管疾患
  • 感染症
  • 代謝性疾患
  • 神経疾患
  • 腫瘍
  • 眼疾患
  • 呼吸器疾患

第9章 南北アメリカの生物製剤受託製造市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋の生物製剤受託製造市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ

第11章 欧州、中東・アフリカの生物製剤受託製造市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品満足度
  • 市場ランキング分析
  • 市場シェア分析:主要企業別
  • 競合シナリオ
    • 合併・買収
    • 合意・コラボレーション・パートナーシップ
    • 新製品の発売・強化
    • 投資・資金調達
    • 評価・認知・拡大

第13章 企業のユーザビリティプロファイル

  • AbbVie, Inc.
  • Abzena Plc.
  • AGC Biologics
  • Ajinomoto Co., Inc.
  • Avid Bioservices, Inc.
  • Binex Co., Ltd.
  • Boehringer Ingelheim GmbH
  • Cambrex Corporation
  • Catalent, Inc.
  • Emergent BioSolutions Inc.
  • Fujifilm Holding Corporation
  • JSR Life Sciences, LLC
  • Lonza Group AG
  • ProBioGen AG
  • Recipharm AB
  • Rentschler Biotechnologie GmbH
  • Samsung Biologics Co., Ltd.
  • Siegfried Holding AG
  • Thermo Fisher Scientific, Inc.
  • Toyobo Co. Ltd.
  • WuXi Biologics Inc.

第14章 付録

  • ディスカッションガイド
  • ライセンス・価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: DYNAMICS
  • FIGURE 2. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
  • FIGURE 3. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD BILLION)
  • FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2027
  • FIGURE 5. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, 2019-2027 (USD BILLION)
  • FIGURE 6. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 7. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INSULIN, 2019-2027 (USD BILLION)
  • FIGURE 8. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INSULIN, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 9. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INTERFERONS, 2019-2027 (USD BILLION)
  • FIGURE 10. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INTERFERONS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 11. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2019-2027 (USD BILLION)
  • FIGURE 12. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 13. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT HORMONES, 2019-2027 (USD BILLION)
  • FIGURE 14. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT HORMONES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 15. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, 2019-2027 (USD BILLION)
  • FIGURE 16. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 17. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2021 VS 2027 (%)
  • FIGURE 18. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2021 VS 2027 (USD BILLION)
  • FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2027
  • FIGURE 20. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, 2019-2027 (USD BILLION)
  • FIGURE 21. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 22. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL, 2019-2027 (USD BILLION)
  • FIGURE 23. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 24. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2021 VS 2027 (%)
  • FIGURE 25. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2021 VS 2027 (USD BILLION)
  • FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2027
  • FIGURE 27. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISEASES, 2019-2027 (USD BILLION)
  • FIGURE 28. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 29. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2019-2027 (USD BILLION)
  • FIGURE 30. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 31. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, 2019-2027 (USD BILLION)
  • FIGURE 32. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 33. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY METABOLIC DISEASES, 2019-2027 (USD BILLION)
  • FIGURE 34. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 35. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, 2019-2027 (USD BILLION)
  • FIGURE 36. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 37. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2019-2027 (USD BILLION)
  • FIGURE 38. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 39. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, 2019-2027 (USD BILLION)
  • FIGURE 40. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 41. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDERS, 2019-2027 (USD BILLION)
  • FIGURE 42. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 43. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 44. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 45. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 46. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 47. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 48. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 49. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 50. AUSTRALIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 51. CHINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 52. INDIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 53. INDONESIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 54. JAPAN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 55. MALAYSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 56. PHILIPPINES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 57. SINGAPORE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 58. SOUTH KOREA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 59. TAIWAN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 60. THAILAND BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 61. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 62. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 63. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 64. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 65. NETHERLANDS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 66. QATAR BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 67. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 68. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 69. SOUTH AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 70. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 71. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 72. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 73. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: FPNV POSITIONING MATRIX
  • FIGURE 74. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2021
  • FIGURE 75. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
  • TABLE 4. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 5. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 6. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 7. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 8. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILAR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 9. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INSULIN, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 10. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INSULIN, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 11. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INSULIN, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 12. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INSULIN, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 13. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INSULIN, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 14. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INTERFERONS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 15. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INTERFERONS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 16. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INTERFERONS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 17. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INTERFERONS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 18. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INTERFERONS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 19. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 20. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 21. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 22. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 23. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 24. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT HORMONES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 25. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT HORMONES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 26. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT HORMONES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 27. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT HORMONES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 28. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT HORMONES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 29. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 30. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 31. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 32. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 33. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 34. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY PLATFORM, 2019-2027 (USD BILLION)
  • TABLE 35. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 36. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 37. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 38. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 39. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MAMMALIAN, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 40. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 41. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 42. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 43. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 44. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIAL, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 45. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2019-2027 (USD BILLION)
  • TABLE 46. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 47. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 48. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 49. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 50. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 51. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 52. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 53. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 54. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 56. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 57. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 58. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 59. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 61. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 62. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY METABOLIC DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 63. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY METABOLIC DISEASES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 64. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY METABOLIC DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY METABOLIC DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 66. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 67. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 68. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 69. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 71. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 72. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 73. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 74. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 76. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 77. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 78. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 79. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY OPHTHALMOLOGY, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 81. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 82. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 83. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDERS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 84. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, BY RESPIRATORY DISORDERS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 86. AMERICAS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 87. ARGENTINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 88. BRAZIL BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 89. CANADA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 90. MEXICO BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 91. UNITED STATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 92. ASIA-PACIFIC BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 93. AUSTRALIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 94. CHINA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 95. INDIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 96. INDONESIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 97. JAPAN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 98. MALAYSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 99. PHILIPPINES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 100. SINGAPORE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 101. SOUTH KOREA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 102. TAIWAN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 103. THAILAND BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 105. FRANCE BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 106. GERMANY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 107. ITALY BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 108. NETHERLANDS BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 109. QATAR BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 110. RUSSIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 111. SAUDI ARABIA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 112. SOUTH AFRICA BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 113. SPAIN BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 114. UNITED ARAB EMIRATES BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 115. UNITED KINGDOM BIOLOGICS CONTRACT MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 116. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: SCORES
  • TABLE 117. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: BUSINESS STRATEGY
  • TABLE 118. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: PRODUCT SATISFACTION
  • TABLE 119. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: RANKING
  • TABLE 120. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: SHARE, BY KEY PLAYER, 2021
  • TABLE 121. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: MERGER & ACQUISITION
  • TABLE 122. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 123. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 124. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: INVESTMENT & FUNDING
  • TABLE 125. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 126. GLOBAL BIOLOGICS CONTRACT MANUFACTURING MARKET: LICENSE & PRICING
目次
Product Code: MRR-8C74ADFBFD6F

The Global Biologics Contract Manufacturing Market grew USD 41.92 billion by 2027, at a CAGR of 16.32%.

The Global Biologics Contract Manufacturing Market size was estimated at USD 16.92 billion in 2021 and expected to reach USD 19.64 billion in 2022, and is projected to grow at a CAGR 16.32% to reach USD 41.92 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Biologics Contract Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market was studied across Biosimilar, Insulin, Interferons, Monoclonal Antibodies, Recombinant Hormones, and Vaccines.

Based on Platform, the market was studied across Mammalian and Microbial.

Based on Therapeutic Area, the market was studied across Autoimmune Diseases, Cardiovascular Diseases, Infectious Diseases, Metabolic Diseases, Neurology, Oncology, Ophthalmology, and Respiratory Disorders.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Biologics Contract Manufacturing market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biologics Contract Manufacturing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biologics Contract Manufacturing Market, including AbbVie, Inc., Abzena Plc., AGC Biologics, Ajinomoto Co., Inc., Avid Bioservices, Inc., Binex Co., Ltd., Boehringer Ingelheim GmbH, Cambrex Corporation, Catalent, Inc., Emergent BioSolutions Inc., Fujifilm Holding Corporation, JSR Life Sciences, LLC, Lonza Group AG, ProBioGen AG, Recipharm AB, Rentschler Biotechnologie GmbH, Samsung Biologics Co., Ltd., Siegfried Holding AG, Thermo Fisher Scientific, Inc., Toyobo Co. Ltd., and WuXi Biologics Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Biologics Contract Manufacturing Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biologics Contract Manufacturing Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biologics Contract Manufacturing Market?
  • 4. What is the competitive strategic window for opportunities in the Global Biologics Contract Manufacturing Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Biologics Contract Manufacturing Market?
  • 6. What is the market share of the leading vendors in the Global Biologics Contract Manufacturing Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Biologics Contract Manufacturing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for biosimilars and vaccine production
      • 5.1.1.2. Ongoing investment activities by CMOs for capacity expansion
      • 5.1.1.3. Key advantages such as cost and time saving offered by contract services
    • 5.1.2. Restraints
      • 5.1.2.1. Changing trade policies between countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of single-use bioprocessing equipment & solutions
      • 5.1.3.2. Rising demand for cell and gene therapies for targeted treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns over the breach of intellectual property and patents
  • 5.2. Cumulative Impact of COVID-19

6. Biologics Contract Manufacturing Market, by Product

  • 6.1. Introduction
  • 6.2. Biosimilar
  • 6.3. Insulin
  • 6.4. Interferons
  • 6.5. Monoclonal Antibodies
  • 6.6. Recombinant Hormones
  • 6.7. Vaccines

7. Biologics Contract Manufacturing Market, by Platform

  • 7.1. Introduction
  • 7.2. Mammalian
  • 7.3. Microbial

8. Biologics Contract Manufacturing Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Cardiovascular Diseases
  • 8.4. Infectious Diseases
  • 8.5. Metabolic Diseases
  • 8.6. Neurology
  • 8.7. Oncology
  • 8.8. Ophthalmology
  • 8.9. Respiratory Disorders

9. Americas Biologics Contract Manufacturing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biologics Contract Manufacturing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand

11. Europe, Middle East & Africa Biologics Contract Manufacturing Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Key Player
  • 12.4. Competitive Scenario
    • 12.4.1. Merger & Acquisition
    • 12.4.2. Agreement, Collaboration, & Partnership
    • 12.4.3. New Product Launch & Enhancement
    • 12.4.4. Investment & Funding
    • 12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. AbbVie, Inc.
  • 13.2. Abzena Plc.
  • 13.3. AGC Biologics
  • 13.4. Ajinomoto Co., Inc.
  • 13.5. Avid Bioservices, Inc.
  • 13.6. Binex Co., Ltd.
  • 13.7. Boehringer Ingelheim GmbH
  • 13.8. Cambrex Corporation
  • 13.9. Catalent, Inc.
  • 13.10. Emergent BioSolutions Inc.
  • 13.11. Fujifilm Holding Corporation
  • 13.12. JSR Life Sciences, LLC
  • 13.13. Lonza Group AG
  • 13.14. ProBioGen AG
  • 13.15. Recipharm AB
  • 13.16. Rentschler Biotechnologie GmbH
  • 13.17. Samsung Biologics Co., Ltd.
  • 13.18. Siegfried Holding AG
  • 13.19. Thermo Fisher Scientific, Inc.
  • 13.20. Toyobo Co. Ltd.
  • 13.21. WuXi Biologics Inc.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing